• Home
  • Pharmaceuticals and Healthcare
Nanotechnology Drug Delivery Systems Market - Global Outlook and Forecast 2021-2027

Nanotechnology Drug Delivery Systems Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687485 | No. of Pages: 102 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2021 
This report contains market size and forecasts of Nanotechnology Drug Delivery Systems in Global, including the following market information:
Global Nanotechnology Drug Delivery Systems Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Nanotechnology Drug Delivery Systems market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nanotechnology Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nanotechnology Drug Delivery Systems Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Nanotechnology Drug Delivery Systems Market Segment Percentages, By Type, 2020 (%)
Nanocrystals
Nanoparticles
Dendrimers
Gold Nanoparticles
Fullerenes
Liposomes
Nanotubes
Others

China Nanotechnology Drug Delivery Systems Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Nanotechnology Drug Delivery Systems Market Segment Percentages, By Application, 2020 (%)
Immunology
Cardiovascular
Neurology
Oncology
Others

Global Nanotechnology Drug Delivery Systems Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Nanotechnology Drug Delivery Systems Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Nanotechnology Drug Delivery Systems Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Nanotechnology Drug Delivery Systems Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
AbbVie, Inc.
Amgen Inc.
Celgene Corporation
Johnson & Johnson
Merck & Co., Inc.
Novartis International AG
Perrigo Company plc
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
3M
Zosano Pharma
Becton-Dickinson（BD）Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect
Vaxxas
Lohmann Therapie-Systeme AG
1 Introduction to Research & Analysis Reports
    1.1 Nanotechnology Drug Delivery Systems Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Nanotechnology Drug Delivery Systems Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Nanotechnology Drug Delivery Systems Overall Market Size
    2.1 Global Nanotechnology Drug Delivery Systems Market Size: 2021 VS 2027
    2.2 Global Nanotechnology Drug Delivery Systems Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Nanotechnology Drug Delivery Systems Players in Global Market
    3.2 Top Global Nanotechnology Drug Delivery Systems Companies Ranked by Revenue
    3.3 Global Nanotechnology Drug Delivery Systems Revenue by Companies
    3.4 Top 3 and Top 5 Nanotechnology Drug Delivery Systems Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Nanotechnology Drug Delivery Systems Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Nanotechnology Drug Delivery Systems Players in Global Market
        3.6.1 List of Global Tier 1 Nanotechnology Drug Delivery Systems Companies
        3.6.2 List of Global Tier 2 and Tier 3 Nanotechnology Drug Delivery Systems Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Nanotechnology Drug Delivery Systems Market Size Markets, 2021 & 2027
        4.1.2 Nanocrystals
        4.1.3 Nanoparticles
        4.1.4 Dendrimers
        4.1.5 Gold Nanoparticles
        4.1.6 Fullerenes
        4.1.7 Liposomes
        4.1.8 Nanotubes
        4.1.9 Others
    4.2 By Type - Global Nanotechnology Drug Delivery Systems Revenue & Forecasts
        4.2.1 By Type - Global Nanotechnology Drug Delivery Systems Revenue, 2016-2021
        4.2.2 By Type - Global Nanotechnology Drug Delivery Systems Revenue, 2022-2027
        4.2.3 By Type - Global Nanotechnology Drug Delivery Systems Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Nanotechnology Drug Delivery Systems Market Size, 2021 & 2027
        5.1.2 Immunology
        5.1.3 Cardiovascular
        5.1.4 Neurology
        5.1.5 Oncology
        5.1.6 Others
    5.2 By Application - Global Nanotechnology Drug Delivery Systems Revenue & Forecasts
        5.2.1 By Application - Global Nanotechnology Drug Delivery Systems Revenue, 2016-2021
        5.2.2 By Application - Global Nanotechnology Drug Delivery Systems Revenue, 2022-2027
        5.2.3 By Application - Global Nanotechnology Drug Delivery Systems Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Nanotechnology Drug Delivery Systems Market Size, 2021 & 2027
    6.2 By Region - Global Nanotechnology Drug Delivery Systems Revenue & Forecasts
        6.2.1 By Region - Global Nanotechnology Drug Delivery Systems Revenue, 2016-2021
        6.2.2 By Region - Global Nanotechnology Drug Delivery Systems Revenue, 2022-2027
        6.2.3 By Region - Global Nanotechnology Drug Delivery Systems Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Nanotechnology Drug Delivery Systems Revenue, 2016-2027
        6.3.2 US Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.3.3 Canada Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.3.4 Mexico Nanotechnology Drug Delivery Systems Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Nanotechnology Drug Delivery Systems Revenue, 2016-2027
        6.4.2 Germany Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.4.3 France Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.4.4 U.K. Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.4.5 Italy Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.4.6 Russia Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.4.7 Nordic Countries Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.4.8 Benelux Nanotechnology Drug Delivery Systems Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Nanotechnology Drug Delivery Systems Revenue, 2016-2027
        6.5.2 China Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.5.3 Japan Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.5.4 South Korea Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.5.5 Southeast Asia Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.5.6 India Nanotechnology Drug Delivery Systems Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Nanotechnology Drug Delivery Systems Revenue, 2016-2027
        6.6.2 Brazil Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.6.3 Argentina Nanotechnology Drug Delivery Systems Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Nanotechnology Drug Delivery Systems Revenue, 2016-2027
        6.7.2 Turkey Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.7.3 Israel Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.7.4 Saudi Arabia Nanotechnology Drug Delivery Systems Market Size, 2016-2027
        6.7.5 UAE Nanotechnology Drug Delivery Systems Market Size, 2016-2027
7 Players Profiles
    7.1 AbbVie, Inc.
        7.1.1 AbbVie, Inc. Corporate Summary
        7.1.2 AbbVie, Inc. Business Overview
        7.1.3 AbbVie, Inc. Nanotechnology Drug Delivery Systems Major Product Offerings
        7.1.4 AbbVie, Inc. Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.1.5 AbbVie, Inc. Key News
    7.2 Amgen Inc.
        7.2.1 Amgen Inc. Corporate Summary
        7.2.2 Amgen Inc. Business Overview
        7.2.3 Amgen Inc. Nanotechnology Drug Delivery Systems Major Product Offerings
        7.2.4 Amgen Inc. Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.2.5 Amgen Inc. Key News
    7.3 Celgene Corporation
        7.3.1 Celgene Corporation Corporate Summary
        7.3.2 Celgene Corporation Business Overview
        7.3.3 Celgene Corporation Nanotechnology Drug Delivery Systems Major Product Offerings
        7.3.4 Celgene Corporation Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.3.5 Celgene Corporation Key News
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Corporate Summary
        7.4.2 Johnson & Johnson Business Overview
        7.4.3 Johnson & Johnson Nanotechnology Drug Delivery Systems Major Product Offerings
        7.4.4 Johnson & Johnson Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.4.5 Johnson & Johnson Key News
    7.5 Merck & Co., Inc.
        7.5.1 Merck & Co., Inc. Corporate Summary
        7.5.2 Merck & Co., Inc. Business Overview
        7.5.3 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Major Product Offerings
        7.5.4 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.5.5 Merck & Co., Inc. Key News
    7.6 Novartis International AG
        7.6.1 Novartis International AG Corporate Summary
        7.6.2 Novartis International AG Business Overview
        7.6.3 Novartis International AG Nanotechnology Drug Delivery Systems Major Product Offerings
        7.6.4 Novartis International AG Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.6.5 Novartis International AG Key News
    7.7 Perrigo Company plc
        7.7.1 Perrigo Company plc Corporate Summary
        7.7.2 Perrigo Company plc Business Overview
        7.7.3 Perrigo Company plc Nanotechnology Drug Delivery Systems Major Product Offerings
        7.4.4 Perrigo Company plc Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.7.5 Perrigo Company plc Key News
    7.8 Pfizer, Inc.
        7.8.1 Pfizer, Inc. Corporate Summary
        7.8.2 Pfizer, Inc. Business Overview
        7.8.3 Pfizer, Inc. Nanotechnology Drug Delivery Systems Major Product Offerings
        7.8.4 Pfizer, Inc. Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.8.5 Pfizer, Inc. Key News
    7.9 Teva Pharmaceutical Industries Ltd.
        7.9.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
        7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
        7.9.3 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Major Product Offerings
        7.9.4 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.9.5 Teva Pharmaceutical Industries Ltd. Key News
    7.10 3M
        7.10.1 3M Corporate Summary
        7.10.2 3M Business Overview
        7.10.3 3M Nanotechnology Drug Delivery Systems Major Product Offerings
        7.10.4 3M Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.10.5 3M Key News
    7.11 Zosano Pharma
        7.11.1 Zosano Pharma Corporate Summary
        7.11.2 Zosano Pharma Business Overview
        7.11.3 Zosano Pharma Nanotechnology Drug Delivery Systems Major Product Offerings
        7.11.4 Zosano Pharma Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.11.5 Zosano Pharma Key News
    7.12 Becton-Dickinson（BD）Technologies
        7.12.1 Becton-Dickinson（BD）Technologies Corporate Summary
        7.12.2 Becton-Dickinson（BD）Technologies Business Overview
        7.12.3 Becton-Dickinson（BD）Technologies Nanotechnology Drug Delivery Systems Major Product Offerings
        7.12.4 Becton-Dickinson（BD）Technologies Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.12.5 Becton-Dickinson（BD）Technologies Key News
    7.13 Nanopass Technologies
        7.13.1 Nanopass Technologies Corporate Summary
        7.13.2 Nanopass Technologies Business Overview
        7.13.3 Nanopass Technologies Nanotechnology Drug Delivery Systems Major Product Offerings
        7.13.4 Nanopass Technologies Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.13.5 Nanopass Technologies Key News
    7.14 Corium
        7.14.1 Corium Corporate Summary
        7.14.2 Corium Business Overview
        7.14.3 Corium Nanotechnology Drug Delivery Systems Major Product Offerings
        7.14.4 Corium Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.14.5 Corium Key News
    7.15 Valeritas
        7.15.1 Valeritas Corporate Summary
        7.15.2 Valeritas Business Overview
        7.15.3 Valeritas Nanotechnology Drug Delivery Systems Major Product Offerings
        7.15.4 Valeritas Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.15.5 Valeritas Key News
    7.16 Nitto
        7.16.1 Nitto Corporate Summary
        7.16.2 Nitto Business Overview
        7.16.3 Nitto Nanotechnology Drug Delivery Systems Major Product Offerings
        7.16.4 Nitto Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.16.5 Nitto Key News
    7.17 Microdermics
        7.17.1 Microdermics Corporate Summary
        7.17.2 Microdermics Business Overview
        7.17.3 Microdermics Nanotechnology Drug Delivery Systems Major Product Offerings
        7.17.4 Microdermics Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.17.5 Microdermics Key News
    7.18 TheraJect
        7.18.1 TheraJect Corporate Summary
        7.18.2 TheraJect Business Overview
        7.18.3 TheraJect Nanotechnology Drug Delivery Systems Major Product Offerings
        7.18.4 TheraJect Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.18.5 TheraJect Key News
    7.19 Vaxxas
        7.19.1 Vaxxas Corporate Summary
        7.19.2 Vaxxas Business Overview
        7.19.3 Vaxxas Nanotechnology Drug Delivery Systems Major Product Offerings
        7.19.4 Vaxxas Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.19.5 Vaxxas Key News
    7.20 Lohmann Therapie-Systeme AG
        7.20.1 Lohmann Therapie-Systeme AG Corporate Summary
        7.20.2 Lohmann Therapie-Systeme AG Business Overview
        7.20.3 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Major Product Offerings
        7.20.4 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Revenue in Global (2016-2021)
        7.20.5 Lohmann Therapie-Systeme AG Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com